Fig. 2
Forest plot showing the effect of glucagon-like peptide-1 (GLP-1) receptor agonists on creatinine levels in terms of the weighted mean difference and 95% fiducial intervals
Fig. 2 | BMC Endocrine Disorders
Forest plot showing the effect of glucagon-like peptide-1 (GLP-1) receptor agonists on creatinine levels in terms of the weighted mean difference and 95% fiducial intervals